Article thumbnail

Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase

By Jee-Hyun Kim, Jun-Rong Wei, Joshua B. Wallach, Rebekkah S. Robbins, Eric J. Rubin and Dirk Schnappinger

Abstract

Using a component of the Escherichia coli protein degradation machinery, we have established a system to regulate protein stability in mycobacteria. A protein tag derived from the E. coli SsrA degradation signal did not affect several reporter proteins in wild-type Mycobacterium smegmatis or Mycobacterium tuberculosis. Expression of the adaptor protein SspB, which recognizes this modified tag and helps deliver tagged proteins to the protease ClpXP, strongly decreased the activities and protein levels of different reporters. This inactivation did not occur when the function of ClpX was inhibited. Using this system, we constructed a conditional M. smegmatis knockdown mutant in which addition of anhydrotetracycline (atc) caused depletion of the beta subunit of RNA polymerase, RpoB. The impact of atc on this mutant was dose-dependent. Very low amounts of atc did not prevent growth but increased sensitivity to an antibiotic that inactivates RpoB. Intermediate amounts of RpoB knockdown resulted in bacteriostasis and a more substantial depletion led to a decrease in viability by up to 99%. These studies identify SspB-mediated proteolysis as an efficient approach to conditionally inactivate essential proteins in mycobacteria. They further demonstrate that depletion of RpoB by ∼93% is sufficient to cause death of M. smegmatis

Topics: Molecular Biology
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:3064785
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A common mechanism of cellular death induced by bactericidal antibiotics.
  2. (2008). A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor.
  3. (2000). A specificity-enhancing factor for the ClpXP degradation machine.
  4. (2009). Bacterial RNA polymerase inhibitors: an organized overview of their structure, derivatives, biological activity and current clinical development status.
  5. (2008). Biology of trans-translation.
  6. (2009). CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence.
  7. (2009). Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by Iron
  8. (2005). Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.
  9. (2002). Degradation of a Caulobacter soluble cytoplasmic chemoreceptor is ClpX dependent.
  10. (2002). Destabilized green fluorescent protein for monitoring transient changes in mycobacterial gene expression.
  11. (2003). Development and application of unstable GFP variants to kinetic studies of mycobacterial gene expression.
  12. (2006). Engineering controllable protein degradation.
  13. (1993). Four contiguous amino acids define the target for streptolydigin resistance in the beta subunit of Escherichia coli RNA polymerase.
  14. (2003). Genes required for mycobacterial growth defined by high density mutagenesis.
  15. (2009). Hydroxyurea induces hydroxyl radical-mediated cell death in Escherichia coli.
  16. (2004). Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein.
  17. (2007). In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice.
  18. (2008). Inducible protein degradation in Bacillus subtilis using heterologous peptide tags and adaptor proteins to target substrates to the protease ClpXP.
  19. (1971). Inhibition of RNA polymerase by streptolydigin.
  20. (2008). Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death.
  21. (2000). Molecular Genetics of Mycobacteria.
  22. (2009). Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition.
  23. (1978). On the mechanism of rifampicin inhibition of RNA synthesis.
  24. (1980). On the mechanism of streptolydigin inhibition of Escherichia coli RNA polymerase.
  25. (2001). Overlapping recognition determinants within the ssrA degradation tag allow modulation of proteolysis.
  26. (2009). Pristinamycin-inducible gene regulation in mycobacteria.
  27. (2007). Progress in targeting bacterial transcription.
  28. (2003). Proteolysis in bacterial regulatory circuits.
  29. (2007). Proteolytic adaptor for transfer-messenger RNA-tagged proteins from alpha-proteobacteria.
  30. (2001). Refined crystal structure of DsRed, a red fluorescent protein from coral, at 2.0-A resolution.
  31. (2005). Regulated degradation of chromosome replication proteins DnaA and CtrA in Caulobacter crescentus.
  32. (1969). Relationships between bactericidal effect and inhibition of ribonucleic acid nucleotidyltransferase by rifampicin in Escherichia coli K-12.
  33. (1967). Rifampicin: a new rifamycin.
  34. (2010). Rifamycins – Obstacles and opportunities.
  35. (2009). Role of reactive oxygen species in antibiotic action and resistance.
  36. (2007). Silencing essential protein secretion in Mycobacterium smegmatis by using tetracycline repressors.
  37. (2006). Specificity in substrate and cofactor recognition by the N-terminal domain of the chaperone ClpX.
  38. (2008). The communication factor EDF and the toxin-antitoxin module mazEF determine the mode of action of antibiotics.
  39. (2003). The N-terminal zinc binding domain of ClpX is a dimerization domain that modulates the chaperone function.